milnacipran

Known as: (-)-milnacipran, Midalcipran, Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, cis-(+-)- 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2017
0204019852017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Tricyclic antidepressants (TCAs) are among the most effective antidepressants available, although their poor tolerance at usual… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE To evaluate the safety and efficacy of milnacipran, a dual norepinephrine and serotonin reuptake inhibitor, in the… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Brain-derived neurotrophic factor (BDNF) is an important member of the neurotrophin family of growth factors, abundant in the… (More)
Is this relevant?
2007
2007
Prediction of the response to different classes of antidepressants has been an important matter of concern in the field of… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVE Fibromyalgia (FM) is a common musculoskeletal condition characterized by widespread pain, tenderness, and a variety of… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Fibromyalgia syndrome is a systemic disorder of widespread pain which is thought to result from abnormal pain processing within… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Though selective serotonin reuptake inhibitors have revolutionized the field of psychiatry with demonstrated efficacy… (More)
Is this relevant?
2004
2004
OBJECTIVE With a multitude of antidepressants available, predictors of response to different classes of antidepressants are of… (More)
Is this relevant?
2002
2002
Abstract Rationale. The prefrontal cortex is implicated in the pathophysiology of depression, and hypoactivity of this brain area… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
1998
1998
The pharmacokinetics of a single 50 mg dose of milnacipran, a new non tricyclic antidepressant drug, were compared in 8 chronic… (More)
  • table I
  • figure 1
  • figure 2
  • figure 3
Is this relevant?